Related Experiment Video
Updated: Jun 23, 2026

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
BS69 negatively regulates the canonical NF-kappaB activation induced by Epstein-Barr virus-derived LMP1
Osamu Ikeda1, Yuichi Sekine, Akihiro Mizushima
1Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Kita-Ku Kita 12 Nishi 6, Sapporo, Japan.
Insights
BS69 protein negatively regulates Epstein-Barr virus (EBV) LMP1-induced NF-kappaB activation. This study reveals BS69
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) is a key viral oncoprotein.
- LMP1 activates NF-kappaB signaling via its C-terminal regions (CTAR1 and CTAR2).
- BS69 protein was previously linked to LMP1-induced c-Jun N-terminal kinase activation through CTAR2.
Purpose of the Study:
- To investigate the role of BS69 in LMP1-mediated NF-kappaB activation.
- To elucidate the molecular mechanisms by which BS69 influences LMP1 signaling.
Main Methods:
- Manipulation of BS69 expression levels.
- Assessment of NF-kappaB activation.
- Measurement of IL-6 mRNA and IkappaB degradation.
- Immunoprecipitation assays to study protein-protein interactions.
Main Results:
- BS69 negatively regulates LMP1-mediated NF-kappaB activation.
- BS69 up-regulates IL-6 mRNA expression and IkappaB degradation.
- BS69 decreases the formation of complexes between LMP1 and TNFR-associated death domain protein (TRADD).
Conclusions:
- BS69 acts as a negative regulator of LMP1-induced NF-kappaB signaling.
- BS69 influences LMP1 downstream signaling by affecting interactions with TRADD.
- BS69 modulation impacts key inflammatory pathways regulated by EBV.
Abstract:
Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) activates NF-kappaB signaling pathways through the two C-terminal regions, CTAR1 and CTAR2. BS69 has previously been shown to be involved in LMP1-induced c-Jun N-terminal kinase activation through CTAR2 by interacting with tumor necrosis factor (TNFR) receptor-associated factor 6. In the present study, our manipulation of BS69 expression clearly indicates that BS69 negatively regulates LMP1-mediated NF-kappaB activation and up-regulates IL-6 mRNA expression and IkappaB degradation. Our immunoprecipitation experiments suggest that BS69 decreases complex formation between LMP1 and TNFR-associated death domain protein (TRADD).
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Negative Regulator Molecules
Regulation of Nuclear Protein Sorting
Abnormal Proliferation

